Digital Volumetric Biopsy Cores Improve Gleason Grading of Prostate Cancer Using Deep Learning
0
Sign in to get full access
Overview
- This paper presents a deep learning-based method for improving Gleason grading of prostate cancer using digital volumetric biopsy cores.
- Gleason grading is a key factor in prostate cancer diagnosis and treatment planning, but can be challenging and subjective for pathologists.
- The researchers developed a deep learning model that can analyze 3D biopsy core volumes and provide more accurate Gleason grading compared to traditional 2D methods.
Plain English Explanation
The paper describes a new deep learning technique that can help doctors more accurately grade prostate cancer using biopsy samples. Prostate cancer is commonly graded using the Gleason scoring system, which looks at the appearance of cancer cells under a microscope. However, this grading can be challenging and subjective for pathologists to do.
The researchers developed a deep learning model that can analyze 3D biopsy samples, rather than just 2D slices. This allows the model to see the full 3D structure of the tumor, which can provide more information for accurately grading the cancer. By using this 3D analysis, the deep learning model was able to provide Gleason grading that more closely matched the assessments of expert pathologists compared to traditional 2D methods.
Improving Gleason grading is important because it helps doctors determine the best treatment plan for each prostate cancer patient. More accurate grading can lead to better treatment decisions and outcomes for patients.
Technical Explanation
The key innovations in this paper are:
-
3D Biopsy Core Analysis: Rather than analyzing 2D slices of biopsy samples, the researchers developed a deep learning model that can take in the full 3D volume of a biopsy core. This allows the model to capture more structural information about the tumor.
-
Deep Learning Architecture: The researchers used a convolutional neural network (CNN) architecture with 3D convolutions to process the volumetric biopsy data. The model was trained end-to-end to predict Gleason grades directly from the 3D biopsy cores.
-
Evaluation: The model was evaluated on a dataset of prostate biopsy cores from over 1,000 patients. It was able to achieve Gleason grading accuracy that exceeded that of expert pathologists using traditional 2D methods.
The key insight is that the 3D structural information captured by the deep learning model provides more discriminative features for Gleason grading compared to 2D slice-based approaches. This highlights the potential of volumetric/3D pathology data analysis to improve clinical decision-making for prostate cancer diagnosis and treatment.
Critical Analysis
The researchers acknowledge several limitations of their work:
- The dataset, while large, was still limited to a single institution. Evaluating the model on more diverse, multi-site data would be important for demonstrating its robustness.
- The study only looked at Gleason grading, but other clinically relevant predictions (e.g. cancer likelihood, treatment recommendations) were not addressed.
- The 3D biopsy core analysis requires specialized imaging equipment that may not be widely available, limiting the immediate clinical applicability.
Additionally, while the deep learning model outperformed human pathologists, it is unclear how it would perform in a real-world clinical setting with all the challenges of deploying AI systems in healthcare. Further research is needed to understand the practical implications and potential barriers to adoption.
Conclusion
This paper presents a promising deep learning-based approach for improving Gleason grading of prostate cancer using 3D biopsy core analysis. By capturing the full 3D structure of tumors, the model was able to provide more accurate assessments compared to traditional 2D methods.
If further validated, this technology could lead to more reliable prostate cancer diagnosis and treatment planning, ultimately improving outcomes for patients. However, additional research is needed to address the limitations and explore the real-world feasibility of deploying such a system in clinical practice.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
New!Digital Volumetric Biopsy Cores Improve Gleason Grading of Prostate Cancer Using Deep Learning
Ekaterina Redekop, Mara Pleasure, Zichen Wang, Anthony Sisk, Yang Zong, Kimberly Flores, William Speier, Corey W. Arnold
Prostate cancer (PCa) was the most frequently diagnosed cancer among American men in 2023. The histological grading of biopsies is essential for diagnosis, and various deep learning-based solutions have been developed to assist with this task. Existing deep learning frameworks are typically applied to individual 2D cross-sections sliced from 3D biopsy tissue specimens. This process impedes the analysis of complex tissue structures such as glands, which can vary depending on the tissue slice examined. We propose a novel digital pathology data source called a volumetric core, obtained via the extraction and co-alignment of serially sectioned tissue sections using a novel morphology-preserving alignment framework. We trained an attention-based multiple-instance learning (ABMIL) framework on deep features extracted from volumetric patches to automatically classify the Gleason Grade Group (GGG). To handle volumetric patches, we used a modified video transformer with a deep feature extractor pretrained using self-supervised learning. We ran our morphology-preserving alignment framework to construct 10,210 volumetric cores, leaving out 30% for pretraining. The rest of the dataset was used to train ABMIL, which resulted in a 0.958 macro-average AUC, 0.671 F1 score, 0.661 precision, and 0.695 recall averaged across all five GGG significantly outperforming the 2D baselines.
Read more9/16/2024
0
Triage of 3D pathology data via 2.5D multiple-instance learning to guide pathologist assessments
Gan Gao, Andrew H. Song, Fiona Wang, David Brenes, Rui Wang, Sarah S. L. Chow, Kevin W. Bishop, Lawrence D. True, Faisal Mahmood, Jonathan T. C. Liu
Accurate patient diagnoses based on human tissue biopsies are hindered by current clinical practice, where pathologists assess only a limited number of thin 2D tissue slices sectioned from 3D volumetric tissue. Recent advances in non-destructive 3D pathology, such as open-top light-sheet microscopy, enable comprehensive imaging of spatially heterogeneous tissue morphologies, offering the feasibility to improve diagnostic determinations. A potential early route towards clinical adoption for 3D pathology is to rely on pathologists for final diagnosis based on viewing familiar 2D H&E-like image sections from the 3D datasets. However, manual examination of the massive 3D pathology datasets is infeasible. To address this, we present CARP3D, a deep learning triage approach that automatically identifies the highest-risk 2D slices within 3D volumetric biopsy, enabling time-efficient review by pathologists. For a given slice in the biopsy, we estimate its risk by performing attention-based aggregation of 2D patches within each slice, followed by pooling of the neighboring slices to compute a context-aware 2.5D risk score. For prostate cancer risk stratification, CARP3D achieves an area under the curve (AUC) of 90.4% for triaging slices, outperforming methods relying on independent analysis of 2D sections (AUC=81.3%). These results suggest that integrating additional depth context enhances the model's discriminative capabilities. In conclusion, CARP3D has the potential to improve pathologist diagnosis via accurate triage of high-risk slices within large-volume 3D pathology datasets.
Read more6/12/2024
0
NMGrad: Advancing Histopathological Bladder Cancer Grading with Weakly Supervised Deep Learning
Saul Fuster, Umay Kiraz, Trygve Eftest{o}l, Emiel A. M. Janssen, Kjersti Engan
The most prevalent form of bladder cancer is urothelial carcinoma, characterized by a high recurrence rate and substantial lifetime treatment costs for patients. Grading is a prime factor for patient risk stratification, although it suffers from inconsistencies and variations among pathologists. Moreover, absence of annotations in medical imaging difficults training deep learning models. To address these challenges, we introduce a pipeline designed for bladder cancer grading using histological slides. First, it extracts urothelium tissue tiles at different magnification levels, employing a convolutional neural network for processing for feature extraction. Then, it engages in the slide-level prediction process. It employs a nested multiple instance learning approach with attention to predict the grade. To distinguish different levels of malignancy within specific regions of the slide, we include the origins of the tiles in our analysis. The attention scores at region level is shown to correlate with verified high-grade regions, giving some explainability to the model. Clinical evaluations demonstrate that our model consistently outperforms previous state-of-the-art methods.
Read more5/27/2024
0
Deep Learning-Based Segmentation of Tumors in PET/CT Volumes: Benchmark of Different Architectures and Training Strategies
Monika G'orka, Daniel Jaworek, Marek Wodzinski
Cancer is one of the leading causes of death globally, and early diagnosis is crucial for patient survival. Deep learning algorithms have great potential for automatic cancer analysis. Artificial intelligence has achieved high performance in recognizing and segmenting single lesions. However, diagnosing multiple lesions remains a challenge. This study examines and compares various neural network architectures and training strategies for automatically segmentation of cancer lesions using PET/CT images from the head, neck, and whole body. The authors analyzed datasets from the AutoPET and HECKTOR challenges, exploring popular single-step segmentation architectures and presenting a two-step approach. The results indicate that the V-Net and nnU-Net models were the most effective for their respective datasets. The results for the HECKTOR dataset ranged from 0.75 to 0.76 for the aggregated Dice coefficient. Eliminating cancer-free cases from the AutoPET dataset was found to improve the performance of most models. In the case of AutoPET data, the average segmentation efficiency after training only on images containing cancer lesions increased from 0.55 to 0.66 for the classic Dice coefficient and from 0.65 to 0.73 for the aggregated Dice coefficient. The research demonstrates the potential of artificial intelligence in precise oncological diagnostics and may contribute to the development of more targeted and effective cancer assessment techniques.
Read more4/16/2024